Description
Pertuzumab is a monoclonal antibody medication used in the treatment of certain types of cancer, specifically breast cancer. It works by targeting the HER2/neu receptor, a protein that can promote the growth of cancer cells. By blocking this receptor, Pertuzumab helps to slow down or stop the growth of cancer cells.
Indications / Uses
Pertuzumab is commonly prescribed for:
- Early breast cancer: In combination with other medications, Pertuzumab is used to treat early breast cancer that is HER2-positive, helping to reduce the risk of the cancer coming back.
- Metastatic breast cancer: Pertuzumab is also used to treat HER2-positive metastatic breast cancer, in combination with other medications, to help slow down the progression of the disease.
Key Features
- Monoclonal antibody that targets the HER2/neu receptor
- Given by intravenous infusion every 3 weeks
- Can be used in combination with other cancer medications, such as trastuzumab and docetaxel
Storage
Pertuzumab should be stored in the refrigerator at a temperature between 2°C and 8°C. It should not be frozen or exposed to extreme temperatures. The medication should be protected from light and kept out of the reach of children.
Important Note
Pertuzumab can cause serious side effects, including infusion reactions, heart problems, and birth defects. Women who are pregnant or breastfeeding should not use this medication. It is essential to follow the instructions provided by your healthcare provider and to report any side effects or concerns promptly. Additionally, patients should be monitored closely for any signs of cardiac dysfunction or other adverse reactions.
Reviews
There are no reviews yet.